Aymeric Sallin is the Founder and CEO of NanoDimension, a nanotechnology-focused venture capital firm, with offices in Silicon Valley and Switzerland. Since 2002, Aymeric has actively promoted nanotechnology around the world, receiving the “NSTI Fellow Award” and “2012 EPFL Alumni award” for “his entrepreneurial spirit, his dedication and exceptional contribution to the field of nanotechnology”. Recognized as a nanotechnology and innovation leader, Aymeric works closely with the business, government, and academic communities. Aymeric is currently on the Board of Directors of Crocus Technology SA, Selecta Biosciences, Tarveda Therapeutics, H55, and Natron. Aymeric is an elected member of the World Economic Forum’s “Young Global Leaders” Class of 2013. He is the Chairman of the Board of the EPFL Alumni and a member of the Strategic Advisory Board of EPFL (Switzerland).